CVS Health Corporation (CVS) Announced Q1 2026 Earnings on May 6, 2026, Reporting "over $100 billion of revenue".

CVS Health Corporation reported first quarter 2026 financial results, with management noting the company generated "over $100 billion of revenue" for the quarter.

For the first quarter, "adjusted operating income of approximately $5.2 billion" and an "adjusted EPS of $2.57" were reported.

Segment performance for the first quarter included the Health Care Benefits segment generating "nearly $36 billion of revenue in the quarter," the Health Services segment generating "revenues of over $48 billion," and the Pharmacy and Consumer Wellness segment generating "revenues of nearly $32 billion". Management also stated that during the first quarter, the company "generated cash flow from operations of approximately $4.2 billion".Management highlighted a strategic transition, aiming to evolve "from a consumer-based health care company to a consumer-based health care technology company". This includes the upcoming launch of Health100, described by executives as "an AI native, state-of-the-art technology and service platform that allows for any payer, PBM, pharmacy or provider to seamlessly connect". In the Medicare Advantage business, leadership noted that the Final Rate Notice was "a step in the right direction" but "remains insufficient to offset underlying medical cost trends". The company also emphasized efforts to reduce friction, stating that Aetna has integrated technology to "approve more than 95% of the eligible prior authorizations within 24 hours".For full year 2026 forward guidance, CVS Health increased its adjusted earnings per share expectation to "a range of $7.30 to $7.50". The company now expects full year total revenues to be "at least $405 billion" and updated its outlook for full year cash flow from operations to "at least 9.5billion".